Plasma aldosterone during extracellular fluid volume expansion in patients on regular haemodialysis.
The influence of extracellular fluid volume expansion on the plasma aldosterone concentration (PAC) was investigated in five anephric and six non-nephrectomized patients on regular haemodialysis, and compared to a control group of four anephric and four non-nephrectomized patients. Plasma-renin activity, cortisol, Na+, and K+ were measured together with the PAC during the investigation. In anephric patients the PAC remained constant during the control period as well as during extracellular fluid volume expansion by infusion of 350 mmol of 20% mannitol. In the non-nephrectomized patients PAC diminished after mannitol infusion. The decline in PAC was correlated with the basal levels of PAC and the plasma renin activity. It is concluded that 5% extracellular fluid volume expansion has no direct influence on the regulation of PAC in patients without the renal renin-angiotensin system and that the regulation of PAC in anephric patients in the present investigation is probably mediated by changes in potassium and ACTH.
D000328:Adult; D000450:Aldosterone / Q000097:blood*; D005110:Extracellular Space; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood; D008297:Male; D008353:Mannitol / Q000494:pharmacology; D008875:Middle Aged; D009392:Nephrectomy; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood
D008353:Mannitol; D000450:Aldosterone; D012964:Sodium; D012083:Renin; D011188:Potassium; D006854:Hydrocortisone